FDA NDC Directory · JSON-LD · Markdown
NDC 0409-6635 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION, CONCENTRATE
| Labeler / Manufacturer | Hospira, Inc. |
|---|---|
| Marketing category | Abbreviated NDA (generic) · App ANDA080205 |
| Dosage form / route | INJECTION, SOLUTION, CONCENTRATE · INTRAVENOUS |
| Active ingredients | POTASSIUM CHLORIDE (149 mg/mL) |
| Marketing started | 20050919 |
| Package count | 1 |
Source: openFDA. Public-domain (CC0).